Company Filing History:
Years Active: 2014-2015
Title: Innovations of Wolfgang Sadée in Analgesic Formulations
Introduction
Wolfgang Sadée is a notable inventor based in Upper Arlington, OH (US), recognized for his contributions to the field of analgesic formulations. With a total of three patents to his name, he has made significant strides in developing non-addictive pain relief solutions.
Latest Patents
Sadée's latest patents focus on a combination analgesic employing an opioid agonist and a neutral antagonist. One of his inventions provides a non-addictive analgesic co-formulation that includes an opioid agonist in an amount sufficient to confer analgesia in a mammalian subject, along with a neutral opioid antagonist that inhibits peripheral effects without blocking substantial central effects. This formulation is designed for oral administration and aims to deter diversion, inhibit peripheral effects, and reduce addiction liability. Another patent presents a similar non-addictive analgesic co-formulation, emphasizing the same benefits and applications.
Career Highlights
Wolfgang Sadée has established himself as a key figure in the biotechnology sector, particularly through his work at Aiko Biotechnology. His innovative approaches to pain management have garnered attention and respect within the scientific community.
Collaborations
Sadée has collaborated with esteemed colleagues such as Edward J Bilsky and Janet Yancey-Wrona, contributing to the advancement of research in analgesic formulations.
Conclusion
Wolfgang Sadée's work in developing non-addictive analgesic formulations represents a significant advancement in pain management. His innovative patents reflect a commitment to improving patient care while addressing the challenges of addiction.